ZCCHC12, a novel oncogene in papillary thyroid cancer

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants

(2016) Xiaoguang Shi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

(2016) Iñigo Landa et al.   JOURNAL OF CLINICAL INVESTIGATION

Changing Trends in the Incidence of Thyroid Cancer in the United States

(2016) Luc G. T. Morris et al.   JAMA Otolaryngology-Head & Neck Surgery

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Highly prevalent TERT promoter mutations in aggressive thyroid cancers

(2013) Xiaoli Liu et al.   ENDOCRINE-RELATED CANCER

ZCCHC12, a potential molecular marker of papillary thyroid carcinoma: a preliminary study

(2011) Qiu-li Li et al.   MEDICAL ONCOLOGY

Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer

(2010) Mingzhao Xing   THYROID

Human ZCCHC12 activates AP-1 and CREB signaling as a transcriptional co-activator

(2009) H. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

SUMO Interaction Motifs in Sizn1 Are Required for Promyelocytic Leukemia Protein Nuclear Body Localization and for Transcriptional Activation

(2009) Ginam Cho et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Evidence thatSIZN1is a candidate X-linked mental retardation gene

(2008) Ginam Cho et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers

(2008) Zhi Liu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM